Related Experiment Video
Updated: Jul 11, 2025

07:53
Assessment of Neuromuscular Function Using Percutaneous Electrical Nerve Stimulation
Published on: September 13, 2015
22.0K
Functional electrical stimulation cycling-based muscular evaluation method in mechanically ventilated patients.
Thainá de Gomes Figueiredo1, Murillo Frazão2,3, Luiz Augusto Werlang4
1Pernambuco University Heart Hospital/University of Pernambuco, Recife, Brazil.
Artificial Organs
|November 6, 2023
Summary
Functional electrical stimulation cycling (FES-cycling) effectively detects muscle weakness in critically ill patients. Lower stimulation cost during FES-cycling is linked to a significantly higher survival rate.
Area of Science:
- Intensive care medicine
- Neuromuscular physiology
- Rehabilitation technology
Background:
- Intensive care acquired muscle weakness is prevalent in critically ill patients.
- Functional electrical stimulation cycling (FES-cycling) offers a potential nonvolitional method for evaluating this weakness.
Purpose of the Study:
- To determine if FES-cycling can identify muscle dysfunctions in critically ill patients.
- To assess the relationship between detected muscle dysfunction and patient survival rates.
Main Methods:
- A prospective observational study involving 29 critically ill patients and 20 healthy controls.
- Measurement of maximum torque, power, and stimulation cost using FES-cycling.
- Six-month follow-up to evaluate survival rates.
Main Results:
- Critically ill patients exhibited lower torque and power, and higher stimulation cost compared to healthy individuals (p < 0.05).
- A lower stimulation cost was significantly associated with increased survival rates (p < 0.05).
- 62% of patients with stimulation cost < 15,371 μC/W survived, versus 7% with cost > 15,371 μC/W.
Conclusions:
- FES-cycling demonstrates high sensitivity and specificity for detecting muscle disorders.
- Critically ill patients present with reduced muscle torque and power, alongside elevated stimulation cost.
- Stimulation cost is a significant predictor of survival, with lower costs indicating better prognosis.

